The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma.
The use of chemotherapy regimens with moderate or high risk of febrile neutropenia (defined as having a FN incidence of 10% or more) and the respective incidence and clinical management of FN in breast cancer and NHL has not been studied in Belgium. The existence of a medical need for G-CSF primary and secondary prophylaxis with these regimens was investigated in a real-life setting. Nine oncologists and six hematologists from different Belgian general hospitals and university centers were surveyed to collect expert opinion and real-life data (year 2007) on the use of chemotherapy regimens wit... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2010 |
Schlagwörter: | Academic Medical Centers / Adult / Aged / Antineoplastic Combined Chemotherapy Protocols / Belgium / Breast Neoplasms / Female / Fever / Granulocyte Colony-Stimulating Factor / Guideline Adherence / Health Care Surveys / Hospitalization / Hospitals / General / Humans / Incidence / Lymphoma / Non-Hodgkin / Male / Middle Aged / Neutropenia / Practice Guidelines as Topic / Practice Patterns / Physicians' / Retrospective Studies / Time Factors / Treatment Outcome / Young Adult |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28944642 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2078.1/284886 |